Mark Cuban’s Cost Plus Drugs Expands To Employers In Quest To Disrupt Big Pharma
Forbes — December 10, 2022
"Cuban’s company has been criticized for offering a limited number of name-brand drugs and only providing some generic drugs. That system keeps patients 'locked outside in the cold when it comes to brand drugs,' PharmacyChecker vice-president of operations and communications Lucia Mueller told Healthline."